15 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will take a look at 15 biotech and pharmaceutical stocks to buy according to Palo Alto Investors.
Vanda Pharmaceuticals Inc. (VNDA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 3,208,614 | $36,289 | -1% | 0.04% |
| 2. | Palo Alto Investors William Leland Edwards | 2,491,200 | $28,175 | -13% | 2.17% |
| 3. | Millennium Management Israel Englander | 833,992 | $9,432 | +90% | 0% |
| 4. | D E Shaw D. E. Shaw | 669,147 | $7,569 | +7% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 586,000 | $6,628 | +8% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.97 | 3,239 | Large Shareholder, Other | 1,103,617 | 2015-12-16 | Filing | |
| $8.97 | 4,441 | Large Shareholder, Other | 2,740,122 | 2015-12-16 | Filing | |
| $8.97 | 3,490 | Large Shareholder, Other | 2,152,952 | 2015-12-16 | Filing | |
| $8.61 | 93,634 | Large Shareholder, Other | 1,100,378 | 2015-12-11 | Filing | |
| $8.61 | 128,374 | Large Shareholder, Other | 2,735,681 | 2015-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.48 | 2,700 | Director | 6,515 | 2022-06-13 | Filing | |
| $9.90 | 6,441 | Director | 63,064 | 2022-06-02 | Filing | |
| $9.85 | 6,500 | Director | 68,387 | 2022-05-31 | Filing | |
| $11.09 | 12,060 | Officer | 103,851 | 2022-03-02 | Filing | |
| $11.19 | 6,974 | Officer | 100,278 | 2022-03-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 60,150 | $680,295 | 0% | |
| 2. | 24,308 | $274,923 | 0% | |
| 3. | 9,747,619 | $110,246 | 0% | |
| 4. | 4,063,298 | $45,956 | 0% | |
| 5. | 3,775,841 | $42,706 | 0% |
News See All
Were Hedge Funds Right About Vanda Pharmaceuticals Inc. (VNDA)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Is VNDA A Good Stock To Buy Now According To Hedge Funds?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Vanda Pharmaceuticals Inc. (VNDA): Hedge Funds Taking Some Chips Off The Table
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Were Hedge Funds Right About Vanda Pharmaceuticals Inc. (VNDA)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Vanda Pharmaceuticals Inc. (VNDA): Hedge Funds Sticking Around
In this article we will check out the progression of hedge fund sentiment towards Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) and determine whether it is a good investment right now.
Vanda Pharmaceuticals Inc. (VNDA): Hedge Funds In Wait-and-See Mode
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Hedge Funds Have Never Been Less Bullish On Vanda Pharmaceuticals Inc. (VNDA)
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Is Vanda Pharmaceuticals Inc. (VNDA) A Good Stock To Buy?
A market surge in the first quarter, spurred by easing global macroeconomic concerns and Powell's pivot ended up having a positive impact on the markets and many hedge funds as a result.
Is Vanda Pharmaceuticals Inc. (VNDA) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
Billionaire Hedge Funds
